Advanced Ovarian Cancer and Topotecan

Links shared publicly online about this topic

Topotecan Tanks in Advanced Ovarian Cancer - QualityPoint Technologies

qualitypointtech.net — “The latest attempt to improve on platinum/taxane by adding topotecan was unsuccessful, as were 4 previous trials. Medscape Medical NewsView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on October 13, 2010 at 8:37 pm By:

MedicalFeed MedicalFeed Health News Feed

Topotecan Tanks in Advanced Ovarian Cancer: The latest attempt to improve on platinum/taxane by adding topotecan w... http://bit.ly/a2x1PW

2 years ago...

Another Confirmation of the Inactivity of Topotecan in Ovarian Cancer " J. Natl. Cancer Inst.

jnci.oxfordjournals.org — “Another Confirmation of the Inactivity of Topotecan in Ovarian Cancer " J. Natl. Cancer Inst.View full resource at jnci.oxfordjournals.org

  • View Related
  • Share

Most Recently Shared on October 26, 2010 at 2:08 pm By:

JNCI_Now J Nat'l Cancer Inst Medical Journal and Oncology

Editorial on inactivity of topotecan: "Does the addition of topotecan to a platinum and taxane backbone improve... http://fb.me/IsmiXE4Q

2 years ago...

Adding Topotecan to Standard Treatment for Ovarian Cancer Does Not Improve Progression-Free Survival " J. Natl. Cancer Inst.

jnci.oxfordjournals.org — “Adding Topotecan to Standard Treatment for Ovarian Cancer Does Not Improve Progression-Free Survival " J. Natl. Cancer Inst.View full resource at jnci.oxfordjournals.org

  • View Related
  • Share

Most Recently Shared on October 26, 2010 at 2:04 pm By:

JNCI_Now J Nat'l Cancer Inst Medical Journal and Oncology

Topotecan does not improve overall survival in ovarian cancer. Press release and study. http://fb.me/CtSqCUOS

2 years ago...

Oncology Article | Topotecan Ovarian Neoplasms

mdlinx.com — “Topotecan weekly versus conventional 5-day schedule in patients with platinum-resistant ovarian cancer: A randomized multicenter phase II trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study GroupView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on December 7, 2010 at 6:40 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Topotecan weekly versus conventional 5-day schedule in patients with platinum-resistant ovarian cancer... http://bit.ly/fVA9K7 #oncology

1 year ago...

Ovarian Cancer: Adding Topotecan To Standard Treatment Does Not Improve Progression-Free Survival

medicalnewstoday.com — “Adding topotecan to carboplatin plus paclitaxel, the standard treatment for ovarian cancer, does not improve progression-free survival in patients and leads to greater toxicity, according to a stuView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 12, 2010 at 1:37 pm By:

medical_tweets medical_tweets Health News

Ovarian Cancer: Adding Topotecan To Standard Treatment Does Not Improve Progression-Free Survival Adding topotecan to c.. http://dld.bz/znNq

2 years ago...

Study finds inactivity of topotecan regimen to treat ovarian cancer

news-medical.net — “Adding topotecan to carboplatin plus paclitaxel, the standard treatment for ovarian cancer, does not improve progression-free survival in patients and leads to greater toxicity, according to a study published online October 11 in the Journal of the National Cancer Institute.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on October 12, 2010 at 10:05 am By:

OvarianCancer_ Ovarian Cancer OW OW Health

Study finds inactivity of topotecan regimen to treat ovarian cancer: Adding topotecan to carboplatin plus paclitax... http://bit.ly/djUgaz

2 years ago...

Study finds inactivity of topotecan regimen to treat ovarian cancer

news-medical.net — “Adding topotecan to carboplatin plus paclitaxel, the standard treatment for ovarian cancer, does not improve progression-free survival in patients and leads to greater toxicity, according to a study published online October 11 in the Journal of the National Cancer Institute.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on October 12, 2010 at 6:35 am By:

NewsMedical News-Medical.Net Health News

Study finds inactivity of topotecan regimen to treat ovarian cancer: Adding topotecan to carboplatin plus paclitax... http://bit.ly/9WfAV6

2 years ago...

Treatment for Advanced Ovarian Cancer Effective

disabled-world.com — “New treatment regimen shown effective against advanced ovarian cancerView full resource at disabled-world.com

  • View Related
  • Share

Most Recently Shared on June 6, 2010 at 11:31 pm By:

Adding topotecan to standard treatment for ovarian cancer does not improve progression-free survival

physorg.com — “Adding topotecan to carboplatin plus paclitaxel, the standard treatment for ovarian cancer, does not improve progression-free survival in patients and leads to greater toxicity, according to a study published online October 11 in the Journal of the National Cancer Institute.View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on October 11, 2010 at 11:51 pm By:

FightCancer FightCancer Health News

Adding topotecan to standard treatment for ovarian cancer does not improve progression-free survival http://bit.ly/cMGVsi

2 years ago...

Ovarian Cancer

springer.com — “Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of ...View full resource at springer.com

  • View Related
  • Share

Most Recently Shared on March 16, 2012 at 6:27 pm By:

OvarianCancer_ Ovarian Cancer OW OW Health

Ovarian Cancer: Second Editionseries:Cancer Treatment and ResearchOvarian carcinoma continues to be responsible ... http://t.co/GanmC9SK

2 months ago...

Ovarian cancer advances when genes are silenced

eurekalert.org — “Researchers at the Duke Cancer Institute have found evidence of epigenetics at work on a genome-wide scale in cases of ovarian cancer. One major biological signaling pathway in particular was found to contain many genes influenced by DNA methylation -- a mechanism for turning off genes -- in tumor cells.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on December 14, 2010 at 4:41 pm By:

twitterbo Bo Health Site

Ovarian cancer advances when genes are silenced ---> http://dld.bz/ANpD

1 year ago...

Ovarian cancer advances when genes are silenced

labspaces.net — “There are many mechanisms that alter the activity of genes -- direct changes to the DNA code like mutations and deletions, or changes that control when genes are switched on and off, called epigenetic means. Tumor-suppressor genes are often inactivated through epigenetics, which provides an opening for the cancerous growth of cells.View full resource at labspaces.net

  • View Related
  • Share

Most Recently Shared on December 14, 2010 at 4:48 pm By:

LabSpaces Brian Krueger Health News

Ovarian cancer advances when genes are silenced - http://is.gd/iJVou

1 year ago...

Key advances in ovarian cancer (ASCO 2010 ) Video

vodpod.com — “Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Prof Ledermann discusses research demonstrating the effectiveness of combining bevacizumab with chemotherapy as first line treatment of ovarian cancer. A second key presentation was research indicating that PARP inhibitors are effective at treating not just ovarian cancer caused by BRCA mutation but also high grade serous cancer. If this result is confirmed in further studies, it woView full resource at vodpod.com

  • View Related
  • Share

Most Recently Shared on July 22, 2010 at 9:59 pm By:

libbyshope Paul Cacciatore Patient Advocate

Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Pro… http://bit.ly/b7acun

2 years ago...

Ovarian cancer advances when genes are silenced

sciencedaily.com — “Researchers have found evidence of epigenetics at work on a genome-wide scale in cases of ovarian cancer. One major biological signaling pathway in particular was found to contain many genes influenced by DNA methylation -- a mechanism for turning off genes -- in tumor cells.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on December 14, 2010 at 3:38 am By:

OvarianCancer_ Ovarian Cancer OW OW Health

Ovarian cancer advances when genes are silenced: Researchers have found evidence of epigenetics at work on a gen... http://bit.ly/hM8eZ9

1 year ago...

7 Clues to Ovarian Cancer

webmd.com — “Seven symptoms often reported to doctors are associated with ovarian cancer, according to a new study from the U.K., dispelling the idea that the deadly cancer is a ''silent killer'' with few clues until the advanced stages.View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on August 25, 2009 at 11:47 pm By:

WebMD_News WebMD_News Health News

7 Clues to Ovarian Cancer: Seven symptoms often reported to doctors are associated with ovarian cancer, accordin.. http://bit.ly/17OJmo

3 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

  • MedicalFeed

    MedicalFeed

    Medical news and updates about medical articles and discussion in Google knols and in many medical websites.

    View Profile

  • JNCI_Now

    J Nat'l Cancer Inst

    JNCI, an Oxford University Press journal, publishes peer-reviewed original research and is an internationally acclaimed source for cancer news and information.

    View Profile

  • JNCI_Now

    J Nat'l Cancer Inst

    JNCI, an Oxford University Press journal, publishes peer-reviewed original research and is an internationally acclaimed source for cancer news and information.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390